Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether low concentration inhaled carbon monoxide
is effective in treating idiopathic pulmonary fibrosis.
Phase:
Phase 2
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborators:
Columbia University National Heart, Lung, and Blood Institute (NHLBI) Tulane University University of California, San Francisco University of Chicago University of Illinois at Chicago University of Michigan University of Washington